ELEM
1 known investors
ELEM builds healthcare digital twins and virtual human populations that simulate drug and device performance across diverse patient groups, letting pharmaceutical companies, CROs, regulators, and clinicians generate in silico clinical evidence before real trials. Its focus is cardiac safety prediction, reducing late-stage failures, patient risk, and reliance on animal testing across drug discovery, safety, and clinical development.
Investors · 1
Frequently asked questions
- What does ELEM do?
- ELEM builds healthcare digital twins and virtual human populations that simulate drug and device performance across diverse patient groups, letting pharmaceutical companies, CROs, regulators, and clinicians generate in silico clinical evidence before real trials. Its focus is cardiac safety prediction, reducing late-stage failures, patient risk, and reliance on animal testing across drug discovery, safety, and clinical development.
- Who are ELEM's investors?
- ELEM's investors include Capital Cell.